Copy number alterations in enzyme-coding and cancer-causing genes reprogram tumor metabolism

Cancer Research

Volumn 76, Issue 14, 2016, Pages 4058-4067

  Sharma, Ashwini Kumar ^a,b   Eils, Roland ^b,c   König, Rainer ^a,b,d  

^a HANS KNÖLL INSTITUTE   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; TUMOR GENE; GENETICS; METABOLISM; NEOPLASMS; ONCOGENE;

DNA COPY NUMBER VARIATIONS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; ONCOGENES;

EID: 84978505069     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-2350     Document Type: Article

References (50)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
2. Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006;6:924-35.
3. Hurst LD, Pal C, Lercher MJ. The evolutionary dynamics of eukaryotic gene order. Nat Rev Genet 2004;5:299-310.
4. Singer GA, Lloyd AT, Huminiecki LB, Wolfe KH. Clusters of co-expressed genes in mammalian genomes are conserved by natural selection. Mol Biol Evol 2005;22:767-75.
5. Semon M, Duret L. Evolutionary origin and maintenance of coexpressed gene clusters in mammals. Mol Biol Evol 2006;23:1715-23.
6. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, et al. The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 2001;291:1289-92.
7. Cohen BA, Mitra RD, Hughes JD, Church GM. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression. Nat Genet 2000;26:183-6.
8. Lercher MJ, Urrutia AO, Hurst LD. Clustering of housekeeping genes provides a unified model of gene order in the human genome. Nat Genet 2002;31:180-3.
9. Lee JM, Sonnhammer EL. Genomic gene clustering analysis of pathways in eukaryotes. Genome Res 2003;13:875-82.
10. Purmann A, Toedling J, Schueler M, Carninci P, Lehrach H, Hayashizaki Y, et al. Genomic organization of transcriptomes in mammals: coregulation and cofunctionality. Genomics 2007;89:580-7.
11. Davila Lopez M, Martinez Guerra JJ, Samuelsson T. Analysis of gene order conservation in eukaryotes identifies transcriptionally and functionally linked genes. PLoS One 2010;5:e10654.
12. Glinsky GV, Krones-Herzig A, Glinskii AB. Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers. Neoplasia 2003; 5:218-28.
13. Solimini NL, Xu Q, Mermel CH, Liang AC, Schlabach MR, Luo J, et al. Recurrent hemizygous deletions in cancers may optimize proliferative potential. Science 2012;337:104-9.
14. Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, Park PJ, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 2013;155:948-62.
15. Bashashati A, Haffari G, Ding J, Ha G, Lui K, Rosner J, et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer. Genome Biol 2012;13:R124.
16. Gatto F, Nookaew I, Nielsen J. Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma. Proc Natl Acad Sci U S A 2014;111:E866-75.
17. Bertino JR, Waud WR, Parker WB, Lubin M. Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity. Cancer Biol Ther 2014;11:627-32.
18. Carson DA, Nobori T, Kajander EO, Carrera CJ, Kubota M, Yamanaka H. Methylthioadenosine (MeSAdo) phosphorylase deficiency in malignancy. Adv Exp Med Biol 1988;250:179-85.
19. Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012;491:364-73.
20. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008;13:472-82.
21. Sharma AK, Konig R. Metabolic network modeling approaches for investigating the "hungry cancer". Semin Cancer Biol 2013;23:227-34.
22. Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res 2013;41(Database issue):D970-6.
23. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science 2013;339:1546-58.
24. Luo H, Lin Y, Gao F, Zhang CT, Zhang R. DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements. Nucleic Acids Res 2014;42(Database issue):D574-80.
25. Chen WH, Minguez P, Lercher MJ, Bork P. OGEE: an online gene essentiality database. Nucleic Acids Res 2012;40(Database issue):D901-6.
26. Georgi B, Voight BF, Bucan M. From mouse to human: evolutionary genomics analysis of human orthologs of essential genes. PLoS Genet 2013;9:e1003484.
27. Hart T, Brown KR, Sircoulomb F, Rottapel R, Moffat J. Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol Syst Biol 2014;10:733.
28. Wessely F, Bartl M, Guthke R, Li P, Schuster S, Kaleta C. Optimal regulatory strategies for metabolic pathways in Escherichia coli depending on protein costs. Mol Syst Biol 2011;7:515.
29. Wilson D, Charoensawan V, Kummerfeld SK, Teichmann SA. DBD-taxonomically broad transcription factor predictions: new content and functionality.Nucleic Acids Res 2008;36(Database issue):D88-92.
30. Kharchenko P, Church GM, Vitkup D. Expression dynamics of a cellular metabolic network. Mol Syst Biol 2005;1:2005 0016.
31. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013;45:1134-40.
32. Kim TM, Xi R, Luquette LJ, Park RW, Johnson MD, Park PJ. Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res 2013;23:217-27.
33. Berman JJ. Tumor classification: molecular analysis meets Aristotle. BMC Cancer 2004;4:10.
34. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014;158:929-44.
35. Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 2005;27:1677-83.
36. Kryukov GV, Wilson FH, Ruth JR, Paulk J, Tsherniak A, Marlow SE, et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science 2016;351:1214-8.
37. Mavrakis KJ, McDonald ER III, Schlabach MR, Billy E, Hoffman GR, deWeck A, et al. Disordered methionine metabolism in MTAP/ CDKN2A-deleted cancers leads to dependence on PRMT5. Science 2016; 351:1208-13.
38. Ros S, Schulze A. Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism. Cancer Metab 2013;1:8.
39. Jose C, Bellance N, Rossignol R. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 2011;1807: 552-61.
40. Athenstaedt K, Daum G. Phosphatidic acid, a key intermediate in lipid metabolism. Eur J Biochem 1999;266:1-16.
41. Foster DA. Regulation of mTOR by phosphatidic acid? Cancer Res 2007;67:1-4.
42. Sun J, Zhao Z. A comparative study of cancer proteins in the human protein-protein interaction network. BMC Genomics 2010;11Suppl 3:S5.
43. Oltean S, Bates DO. Hallmarks of alternative splicing in cancer. Oncogene 2014;33:5311-18.
44. Thomas MA, Weston B, Joseph M, Wu W, Nekrutenko A, Tonellato PJ. Evolutionary dynamics of oncogenes and tumor suppressor genes: higher intensities of purifying selection than other genes. Mol Biol Evol 2003;20: 964-8.
45. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001;411:41-2.
46. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010;329:1492-9.
47. Kimura M. Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 1977;267: 275-6.
48. Cheng FX, Jia PL, Wang Q, Lin CC, Li WH, Zhao ZM. Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol Biol Evol 2014;31: 2156-69.
49. Koh JL, Brown KR, Sayad A, Kasimer D, Ketela T, Moffat J. COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res 2012;40(Database issue): D957-63.
50. Marcotte R, Brown KR, Suarez F, Sayad A, Karamboulas K, Krzyzanowski PM, et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov 2012;2:172-89.